Clinical Trials Directory

Trials / Unknown

UnknownNCT03228862

Optimal Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Adults

Optimal Initial and Maintenance Doses of Ergocalciferol Supplementation for Treatment of Hypovitaminosis D in Thai Adults: A Randomized, Double-blinded Dose-comparison Study

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
360 (actual)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

To investigate the optimal initial and maintenance doses of vitamin D2 supplementation for the treatment of vitamin D insufficiency in Thai adults, and to determine the prevalence of and risk factors for hypovitaminosis D among Thai adults.

Detailed description

A double-blinded prospective, randomized study undertaken at outpatient clinic of King Chulalongkorn Memorial Hospital. The patients with vitamin D insufficiency were included and divided into three groups according to their initial 25OHD concentrations. Patients are randomly assigned to receive vitamin D2 40000, 60000 or 80000 IU once weekly. Serum 25(OH)D levels are measured at 12 weeks after vitamin D2 supplemetaiton. The patients with 25OHD more than 30ng/mL are enroll into the maintenance phase of the study and are randomly assigned to receive vitamin D2 20000 or 40000 IU once weekly for another 12 months. The 25OHD concentration are measure again at the end of the study.

Conditions

Interventions

TypeNameDescription
DRUGErgocalciferolErgocalciferol 40000, 60000 and 80000 once weekly

Timeline

Start date
2017-05-01
Primary completion
2018-02-01
Completion
2018-02-01
First posted
2017-07-25
Last updated
2017-07-26

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT03228862. Inclusion in this directory is not an endorsement.